Covered recipient · General Payments record
CHARLENE E BORJA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$4,829.06
- Reported across 273 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.90 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $140.45 | 8 |
| Astellas Pharma US Inc | $78.69 | 3 |
| Antares Pharma, Inc. | $46.48 | 2 |
| Abbott Laboratories | $20.45 | 1 |
| DEXCOM, INC. | $19.64 | 1 |
| Daiichi Sankyo Inc. | $19.38 | 1 |
| Exact Sciences Corporation | $17.66 | 1 |
| Merck Sharp & Dohme Corporation | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125332188 | CMS |
| Antares Pharma, Inc. | $18.46 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146450311 | CMS |
| Antares Pharma, Inc. | $28.02 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146450315 | CMS |
| Astellas Pharma US Inc | $24.63 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139305418 | CMS |
| Astellas Pharma US Inc | $28.73 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139401461 | CMS |
| Astellas Pharma US Inc | $25.33 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139432306 | CMS |
| Daiichi Sankyo Inc. | $19.38 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089401965 | CMS |
| Dexcom, Inc. | $19.64 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153290961 | CMS |
| Exact Sciences Corporation | $17.66 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114596218 | CMS |
| Merck Sharp & Dohme LLC | $13.15 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141579510 | CMS |
| PFIZER INC. | $25.28 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131098700 | CMS |
| PFIZER INC. | $24.97 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131180300 | CMS |
| PFIZER INC. | $6.39 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130921717 | CMS |
| PFIZER INC. | $18.45 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131757304 | CMS |
| PFIZER INC. | $6.58 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130944030 | CMS |
| PFIZER INC. | $14.93 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131879127 | CMS |
| PFIZER INC. | $18.85 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131924422 | CMS |
| PFIZER INC. | $25.00 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131017330 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.